SOLY Soliton, Inc.

Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from MD Anderson. The Company’s first commercial product uses rapid pulses of designed acoustic shockwaves to dramatically accelerate the removal of unwanted tattoos. The Company is based in Houston, Texas, and is actively engaged in bringing this device to the market.

$20.82  -0.24 (-1.14%)
As of 11/26/2021 13:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  02/19/2019
Outstanding shares:  21,596,544
Average volume:  101,337
Market cap:   $454,823,217
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    834251100
ISIN:        US8342511008
Sedol:      BJFFL21
Valuation   (See tab for details)
PE ratio:   -1,653.17
PB ratio:   21.05
PS ratio:   0.00
Return on equity:   -83.67%
Net income %:   -4,831.89%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy